Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
India Proposes Regulatory Measures for Precursor Chemicals and Drug Classification

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Politics

India Proposes Regulatory Measures for Precursor Chemicals and Drug Classification

Analysed 2 Sept 2026·2 sources analysed·India·Politics
India Proposes Regulatory Measures for Precursor Chemicals and Drug ClassificationPreviousNext

India is developing regulatory frameworks to enhance oversight of pharmaceutical chemicals and products. The Narcotics Control Bureau is proposing a voluntary code of conduct for precursor chemicals to prevent their diversion into illicit drug manufacturing, involving supply-chain participants in tracking and auditing. Separately, the government plans to require pharmaceutical companies to clearly distinguish biologics from synthetic drugs in licensing and packaging to address regulatory ambiguities, particularly for drugs like semaglutide that can be produced by both methods.

Sentiment
51%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 64/100.

Outlets measured: mint, mint. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 2 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (51/100)

Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

mint broke this story on 2 Sept, 12:51 am. Other outlets followed.

2 Sept, 12:51 am2 sources · 11 h2 Sept, 11:42 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byPrajakta Kale· Political Analyst· editorial standards byOjas Kale
← Previous
Allahabad High Court Quashes NSA Detention of Activist in Noida Workers' Protest
Next →
Vice President Highlights Chhattisgarh's Progress After Overcoming Left Wing Extremism
mint2 Sept, 12:51 am
Centre to require pharmas to distinguish biologics from synthetics Today News
  • 2
    mint2 Sept, 11:42 am
    Legal chemicals are being diverted to make illicit drugs. Here's how India plans to plug the gap Mint
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Narcotics Control BureauMinistry of Home AffairsMinistry of Health and Family WelfareDrugs Technical Advisory BoardDrugs Controller General of IndiaIndian governmentCentral Drugs Standard Control OrganisationUnion ministry of health and family welfare
    Corporate
    Indian Drug Manufacturers' AssociationBioconBharat BiotechIndian Drug Manufacturers AssociationBiological EHRV PharmaCiplaDr Reddy's LaboratoriesGlenmarkMankindHRV Global Life Sciences

    Story context

    Category
    Politics
    Location
    India
    Sources analysed
    2
    Last analysed
    2 Sept 2026
    Key entities
    Pharmaceutical industryIndiaNew DelhiPrecursor (chemistry)Prohibition of drugsNarcotics Control BureauLogisticsChemical substancePharmacovigilanceSupply chainRaw materialChief executive officer